Close
CDMO Safety Testing 2026
Novotech

Press Releases

GeoVax and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 Vaccine Development

GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer, announced that Beijing- and Philadelphia-based Sino Biological, Inc. will be its exclusive supplier of SARS-Cov-2 (COVID-19) bioreagent research products. Under the terms of the...

Quotient Limited Announces CE Mark for its SARS-CoV-2 Antibody Microarray

Quotient Limited, a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, announced that it has completed the process for declaring conformity to the essential requirements of the In Vitro Diagnostics Directive (IVDD 98/79/EC) and has CE marked (Conformitรฉ Europรฉenne) its...

Notable and MDS Foundation Partner on MDS Trials and New Drug Therapies

California-based Notable announced that it has entered a partnership with the MDS Foundation, which is dedicated to providing insight to families on future clinical trials for myelodysplastic syndrome (MDS). Notable will offer a grant to support the MDS Foundationโ€™s education...

Geneius Develops Off-the-Shelf T Cell Therapy Targeting SARS-CoV-2

Geneius Biotechnology is developing T cells as a quasi-personalized, off-the-shelf, therapy and preventive measure against COVID-19. The assumption is that by increasing the number of antigen-specific T cells in the body, the patientโ€™s immune system can overwhelm the SARS-CoV-2...

Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine Against Novel Coronavirus

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, and Lonza Ltd. announced a 10-year strategic collaboration agreement to enable larger scale manufacture of...

Fujifilm Diosynth Biotechnologies Teams with COVID-19 Therapeutics Accelerator

FUJIFILM Diosynth Biotechnologies, a world leading biologics-Contract Development and Manufacturing Organization (CDMO), announced that it will reserve manufacturing capacity for a future COVID-19 therapy for the COVID-19 Therapeutics Accelerator. The Therapeutics Accelerator is an initiative launched by the Bill...

WuXi Biologics Successfully Completes PFS Filling at its Robotic Aseptic Filling Facility

WuXi Biologics, a global company with leading open-access biologics technology platforms, announced that its robotic aseptic filling isolator facility (DP4) has successfully completed the filling of two batches of pre-filled syringes (PFS). Using Vanrx SA25 to fill the two batches,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป